N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Sharp, Christopher D ^a   Houghton, J ^a   Elrod, J W ^a   Warren, A ^a   Jackson IV, T H ^a   Jawahar, A ^b   Nanda, A ^b   Minagar, A ^a   Alexander, J S ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Arachidonic acid; Brain; Human; Mitochondria; Reactive oxygen species; Reduced nicotinamide adenine dinucleotide oxidase

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ARACHIDONIC ACID; CALCIUM; CALCIUM ANTAGONIST; CYCLOSPORIN A; CYTOCHROME P450; DIHYDRORHODAMINE; DIPHENYLIODONIUM SALT; DIZOCILPINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; ITRACONAZOLE; LANTHANUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RHODAMINE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; BRAIN MITOCHONDRION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SWINE;

BRAIN; CALCIUM CHANNELS; CELL LINE, TRANSFORMED; ENDOTHELIAL CELLS; GLUTAMIC ACID; HUMANS; LIGANDS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SECOND MESSENGER SYSTEMS; TIGHT JUNCTIONS;

EID: 15744362982     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01110.2003     Document Type: Article

References (48)

1. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20: 131-147, 2000.
2. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200: 629-638, 2002.
3. Abbott NJ and Romero IA. Transporting therapeutics across the blood-brain barrier. Mol Med Today 2: 106-113, 1996.
4. 1 in immortalized rat hepatocytes. J Cell Biochem 89: 254-261, 2003.
5. Alexander JS, Alexander BC, Eppihimer LA, Goodyear N, Haque R, Davis CP, Kalogeris TJ, Carden DL, Zhu YN, and Kevil CG. Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells. Inflammation 24: 99-113, 2000.
6. Alexander JS, Jackson SA, Chaney E, Kevil CG, and Haselton FR. The role of cadherin endocytosis in endothelial barrier regulation: involvement of protein kinase C and actin-cadherin interactions. Inflammation 22: 419-433, 1998.
7. Andersson BS, Aw TY, and Jones DP. Mitochondrial transmembrane potential and pH gradient during anoxia. Am J Physiol Cell Physiol 252: C349-C355, 1987.
8. Bhat GB, Tinsley SB, Tolson JK, Patel JM, and Block ER. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury. J Cell Physiol 151: 228-238, 1992.
9. Brown RC and Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke 33: 1706-1711, 2002.
10. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, and Colgan SP. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277: 14801-14811, 2002.
11. Coyle JT, Bird SJ, Evans RH, Gulley RL, Nadler JV, Nicklas WJ, and Olney JW. Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Neurosci Res Program Bull 19: 1-427, 1981.
12. Coyle JT and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695, 1993.
13. Delius RE. and Hinshaw DB. Metabolic inhibition potentiates oxidant injury. J Surg Res 50: 314-322, 1991.
14. Dempsey RJ, Baskaya MK, and Dogan A. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 47: 399-404, 2000.
15. Duquaine D, Hirsch GA, Chakrabarti A, Han Z, Kehrer C, Brook R, Joseph J, Schott A, Kalyanaraman B, Vasquez-Vivar J, and Rajagopalan S. Rapid-onset endothelial dysfunction with adriamycin; evidence for a dysfunctional nitric oxide synthase. Vasc Med 8: 101-107, 2003.
16. Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera CM, Albertini A, and Visioli O. Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defenses against oxygen toxicity. J Mol Cell Cardiol 17: 937-945, 1985.
17. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42: 1-11, 1984.
18. Fujii Y, Johnson ME, and Gores GJ. Mitochondrial dysfunction during anoxia/reoxygenation injury of liver sinusoidal endothelial cells. Hepatology 20: 177-185, 1994.
19. Gasche Y, Fujimura M, Morita-Fujimura Y, Copin JC, Kawase M, Massengale J, and Chan PH. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 19: 1020-1028, 1999.
20. Gorgulu A, Kins T, Cobanoglu S, Unal F, Izgi NI, Yanik B, and Kucuk M. Reduction of edema and infarction by memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir (Wien) 142: 1287-1292, 2000.
21. Gross SS and Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267: 25722-25729, 1992.
22. Hamann GF, Okada Y, Fitridge R, and del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 26: 2120-2126, 1995.
23. 2. Am J Physiol Heart Circ Physiol 256: H1012-H1022, 1989.
24. Kempski O. Cerebral edema. Semin Nephrol 21: 303-307, 2001.
25. Kempski O, von Andrian U, Schurer L, and Baethmann A. Intravenous glutamate enhances edema formation after a freezing lesion. Adv Neurol 52: 219-223, 1990.
26. Kevil CG, Ohno N, Gute DC, Okayama N, Robinson SA, Chaney E, and Alexander JS. Role of cadherin internalization in hydrogen peroxide-mediated endothelial permeability. Free Radic Biol Med 24: 1015-1022, 1998.
27. 2- mediated permeability. II: importance of tyrosine phosphatase and kinase activity. Am J Physiol Cell Physiol 281: C1940-C1947, 2001.
28. 2-mediated permeability: role of MAPK and occludin. Am J Physiol Cell Physiol 279: C21-C30, 2000.
29. Kevil CG, Oshima T, and Alexander JS. The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium 8: 107-116, 2001.
30. Kevil CG, Payne DK, Mire E, and Alexander JS. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273: 15099-15103, 1998.
31. Kokura S, Yoshida N, and Yoshikawa T. Anoxia/reoxygenation-induced leukocyte-endothelial cell interactions. Free Radic Biol Med 33: 427-432, 2002.
32. Lipton SA and Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622, 1994.
33. Love S. Oxidative stress in brain ischemia. Brain Pathol 9: 119-131, 1999.
34. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 271: 40-47, 1996.
35. Okayama N, Grisham MB, Kevil CG, Eppihimer LA, Wink DA, Alexander JS. Effect of reactive oxygen metabolites on endothelial permeability: role of nitric oxide and iron. Microcirculation 6: 107-116, 1999.
36. Olney JW. Glutamate, a neurotoxic transmitter. J Child Neurol 4: 218-226, 1989.
37. Rosenberg GA. Ischemic brain edema. Prog Cardiovasc Dis 42: 209-216, 1999.
38. Sasaki M, Ostanin D, Elrod JW, Oshima T, Jordan P, Itoh M, Joh T, Minagar A, and Alexander JS. TNF-alpha-induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent. Am J Physiol Cell Physiol 284: C422-C428, 2003.
39. Schuchmann S and Heinemann U. Increased mitochondrial superoxide generation in neurons from Trisomy 16 mice: a model of Down's syndrome. Free Radic Biol Med 28: 235-250, 2000.
40. Schwab S and Hacke W. [Therapy of increased intracranial pressure in space-occupying media infarcts.] Z Arzti Fortbild Qualitatssich 93: 203-208, 1999.
41. Sharp CD, Hines I, Houghton J, Warren A, Jackson TH IV, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, Minagar A, and Alexander JS. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDAR. Am J Physiol Heart Circ Physiol 285: H2592-H2598, 2003.
42. Siflinger-Birnboim A, Goligorsky MS, Del Vecchio PJ, and Malik AB. Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability. Lab Invest 67: 24-30, 1992.
43. 2-induced increase in endothelial permeability. Am J Physiol Lung Cell Mol Physiol 270: L973-L978, 1996.
44. Siflinger-Birnboim A and Malik AB. Regulation of endothelial permeability by second messengers. New Horiz 4: 87-98, 1996.
45. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, and Thomas GR. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28; 2252-2258, 1997.
46. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20: 1430-1442, 2000.
47. Zeevalk GD, Bernard LP, and Nicklas WJ. Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity. Neuroscience 96: 309-316, 2000.
48. Zhang X, Qiu M, Zhang X, Zhang J, Zhang H, and Kang D. Excitatory amino acids in cerebrospinal fluid and their relations with clinical features and outcomes in acute head injury. Chin Med J (Engl) 111: 978-981, 1998.